Additional considerations for studying brain metabolite levels across pain conditions using proton magnetic resonance spectroscopy.
Journal
NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
received:
12
06
2020
revised:
17
09
2020
accepted:
17
09
2020
pubmed:
25
9
2020
medline:
22
1
2021
entrez:
24
9
2020
Statut:
ppublish
Résumé
Advances in proton magnetic resonance spectroscopy (MRS) allow for the non-invasive examination of neuroinhibitory and neuroexcitatory processes in humans. In particular, these methods have been used to understand changes across chronic pain conditions. While a recent meta-analysis supports the idea that underlying brain metabolite levels may be unique to different pain conditions and may serve as biomarkers for specific pain conditions, the lack of consideration of differential brain aging processes across heterogenous pain conditions introduces a significant source of bias. Future studies need to address the interactions between pain and brain aging across different MRS metabolite measures.
Identifiants
pubmed: 32971265
pii: S1053-8119(20)30877-6
doi: 10.1016/j.neuroimage.2020.117392
pii:
doi:
Substances chimiques
Glutamic Acid
3KX376GY7L
gamma-Aminobutyric Acid
56-12-2
Types de publication
Journal Article
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
117392Commentaires et corrections
Type : CommentOn
Informations de copyright
Copyright © 2020. Published by Elsevier Inc.